Austin, I wouldn't rub it in too much. Not worth the effort. But the real question is whether to hold for the trial to finish. The P2 was a 64% better result than standard of care. Lot of upside still coming.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.